Infleqtion director granted 33,928 stock options

Infleqtion, Inc. director David B. Singer received a grant of stock options covering 33,928 shares of common stock.

Rhea-AI Filing Summary

Infleqtion, Inc. director David B. Singer received a grant of stock options covering 33,928 shares of common stock. The options have an exercise price of $12.59 per share and expire on April 10, 2036.

These options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting following April 10, 2026, subject to his continuous service under the company’s 2026 Equity Incentive Plan. Vesting may accelerate under the Non-Employee Director Compensation Policy.

Insider Trade Summary

Grant/Award: 33,928 shares

Grant/Award 1 txn

Insider SINGER DAVID B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	33,928	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 33,928 contracts (Direct)

Footnotes (1)

1. F1. The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy.

Key Figures

Option grant size: 33,928 shares Exercise price: $12.59 per share Total derivative holdings after grant: 33,928 options +2 more

5 metrics

Option grant size 33,928 shares Stock Option (Right to Buy) granted to director

Exercise price $12.59 per share Stock option exercise price for Infleqtion common stock

Total derivative holdings after grant 33,928 options Total options held by David B. Singer following this transaction

Option expiration date April 10, 2036 Expiration of stock option grant

Latest possible vesting date May 23, 2027 Earlier of this date or next annual meeting after April 10, 2026

Key Terms

Stock Option (Right to Buy), Continuous Service, 2026 Equity Incentive Plan, Non-Employee Director Compensation Policy

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

Continuous Service financial

"subject to the Reporting Person's Continuous Service with the Issuer"

2026 Equity Incentive Plan financial

"as defined in the Issuer's 2026 Equity Incentive Plan"

Non-Employee Director Compensation Policy financial

"subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Infleqtion (INFQ) director David B. Singer report on this Form 4?

David B. Singer reported receiving a grant of stock options for 33,928 shares of Infleqtion common stock. These options are a compensation award, not an open-market purchase or sale, and give him the right to buy shares at a fixed exercise price.

How many Infleqtion (INFQ) shares are covered by the new option grant?

The option grant to director David B. Singer covers 33,928 shares of Infleqtion common stock. This entire amount was acquired in a single grant transaction and represents his reported derivative holdings following the award on the transaction date.

What is the exercise price of David B. Singer’s Infleqtion (INFQ) stock options?

The stock options granted to David B. Singer have an exercise price of $12.59 per share. This means he can purchase Infleqtion common stock at $12.59 per share upon exercise, subject to the options vesting and remaining outstanding until then.

When do David B. Singer’s Infleqtion (INFQ) options vest?

The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026. Vesting requires his continuous service with the company through that date under the 2026 Equity Incentive Plan.

When do David B. Singer’s Infleqtion (INFQ) stock options expire?

The stock options granted to David B. Singer expire on April 10, 2036. After that expiration date, any unexercised portion of the 33,928-share option grant will no longer be exercisable, in line with the stated option term.

What conditions affect vesting of the Infleqtion (INFQ) options granted to David B. Singer?

Vesting is conditioned on David B. Singer’s continuous service with Infleqtion, as defined in the 2026 Equity Incentive Plan. The footnote also states vesting is subject to any acceleration provisions in the company’s Non-Employee Director Compensation Policy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 06:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SINGER DAVID B

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE COLORADO 80027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Infleqtion, Inc. [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$12.59	04/10/2026		A		33,928		(1)	04/10/2036	Common Stock	33,928	$0	33,928	D

Explanation of Responses:

1. The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy.

	/s/ Jason D. Hall, Attorney-in-Fact	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)